Skip to main content
Tech.euFundingExplorerBeta

Cellestetix

A biotechnology company focused on discovering, developing and commercializing plant-based exosome formulas for regenerative beauty care applications

Cellestetix has raised €3.4M across 2 funding rounds from 13 investors, most recently a Seed round in Feb 2025. Based in Istanbul, Türkiye; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€3.4M
€3,411,115
Funding rounds
2
Investors
13
distinct backers
Active since
2024-08
latest 2025-02

Funding by year

EUR raised per year
Cellestetix — funding by year — interactive chart.
Data table
Cellestetix — funding by year
2024€1.8M
2025€1.6M

Signals

High confidence
Raise-next likelihood46
base rate 44% for Seed
  • ▲ In typical raise window
  • ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
  • ▼ Young (<3y)
  • ▼ No recent equity round (debt-only or quiet)

Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.

Similar companies

same sector or country

Global coverage: FundingData